Rhythm Pharmaceuticals Inc (RYTM)
59.77
-0.30
(-0.50%)
USD |
NASDAQ |
Nov 14, 16:00
59.74
-0.03
(-0.05%)
After-Hours: 20:00
Rhythm Pharmaceuticals Cash from Financing (Quarterly): 2.492M for Sept. 30, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 2.492M |
| June 30, 2024 | 146.18M |
| March 31, 2024 | 4.243M |
| December 31, 2023 | 2.423M |
| September 30, 2023 | 73.04M |
| June 30, 2023 | -0.965M |
| March 31, 2023 | -0.133M |
| December 31, 2022 | 17.36M |
| September 30, 2022 | 158.56M |
| June 30, 2022 | 37.50M |
| March 31, 2022 | 0.399M |
| December 31, 2021 | 0.10M |
| September 30, 2021 | 0.413M |
| June 30, 2021 | 0.383M |
| March 31, 2021 | 165.58M |
| December 31, 2020 | 0.42M |
| Date | Value |
|---|---|
| September 30, 2020 | 0.699M |
| June 30, 2020 | 0.183M |
| March 31, 2020 | 0.707M |
| December 31, 2019 | 161.96M |
| September 30, 2019 | 0.697M |
| June 30, 2019 | 0.498M |
| March 31, 2019 | 0.316M |
| December 31, 2018 | 0.153M |
| September 30, 2018 | 1.173M |
| June 30, 2018 | 163.36M |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 125.66M |
| September 30, 2017 | 21.16M |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 20.38M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-0.965M
Minimum
Jun 2023
165.58M
Maximum
Mar 2021
38.58M
Average
1.565M
Median
Cash from Financing (Quarterly) Benchmarks
| Eli Lilly and Co | 211.30M |
| TG Therapeutics Inc | 134.45M |
| Regeneron Pharmaceuticals Inc | -634.00M |
| Voyager Therapeutics Inc | 0.571M |
| Mirum Pharmaceuticals Inc | 7.291M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -25.22M |
| Cash from Investing (Quarterly) | -90.82M |
| Free Cash Flow | -124.42M |
| Free Cash Flow Per Share (Quarterly) | 0.2415 |
| Free Cash Flow to Equity (Quarterly) | 14.78M |
| Free Cash Flow to Firm (Quarterly) | 15.96M |
| Free Cash Flow Yield | -3.45% |